Push launch MHRA approves GLP –one receptor agonist semaglutide to lessen danger of significant heart difficulties in obese or overweight adults Semaglutide is the 1st weight loss drug accredited in britain being a preventative cure for anyone with proven cardiovascular diseaseWegovy® is actually a weight loss drug made up of the Lively componen